ProfileGDS5678 / 1447442_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 63% 62% 61% 59% 61% 63% 64% 61% 60% 61% 62% 61% 62% 62% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.8309263
GSM967853U87-EV human glioblastoma xenograft - Control 23.6808562
GSM967854U87-EV human glioblastoma xenograft - Control 33.6653761
GSM967855U87-EV human glioblastoma xenograft - Control 43.5070759
GSM967856U87-EV human glioblastoma xenograft - Control 53.6053161
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.8148563
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.9056364
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.67261
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.5961560
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.6272661
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.680162
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.6079261
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.691662
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.6816362